Carcinoma, Renal Cell: all 1,992 studies
Page 19 of 20. Open to participants first (387), then studies with results posted, then the rest; newest registration first within each.
- Interleukin-2 and Interferon in Treating Patients With Metastatic Kidney CancerCompletedNCT00416871Phase 3
- Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney CancerCompletedNCT00416429Phase 3
- Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney CancerCompletedNCT00405366Early Phase 1
- A Study To Test The Effect Of GW786034 (Pazopanib) On P450 EnzymesCompletedNCT00401583Phase 1
- Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney CancerCompletedNCT00401128Phase 2
- Perifosine + Sunitinib Malate for Patients With Advanced CancersCompletedNCT00399152Phase 1
- Phase I Study of Perifosine + Sorafenib for Patients With Advanced CancersCompletedNCT00398814Phase 1
- TroVax Renal Immunotherapy Survival TrialCompletedNCT00397345Phase 3
- Study of Recombinant Interleukin 21 in Combination With Sorafenib for Metastatic Renal Cell CarcinomaCompletedNCT00389285Phase 1/2
- Study To Assess Long Term Safety Of PazopanibCompletedNCT00387205Phase 1
- Sorafenib and RAD001 Renal Cell CarcinomaCompletedNCT00384969Phase 1
- A Study of ZYC300 Administered With Cyclophosphamide Pre-DosingCompletedNCT00381173Phase 1
- Dose-Finding Study Of CP-675,206 And SU011248 In Patients With Metastatic Renal Cell CarcinomaCompletedNCT00372853Phase 1
- Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney CancerCompletedNCT00365287Phase 1/2
- A Two-way Crossover Study Of The Effect Of Food On The Pharmacokinetics Of Pazopanib In Cancer PatientsCompletedNCT00363194Phase 1
- Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant MelanomaCompletedNCT00356460Phase 1
- Ispinesib in Treating Patients With Metastatic or Unresectable Kidney CancerCompletedNCT00354250Phase 2
- Phase IV Randomization to On-Going Treatment to Evaluate Sustained SorafenibTerminatedNCT00352859Phase 4
- IMP321 Phase 1 Trial in Metastatic Renal Cell Carcinoma (MRCC)CompletedNCT00351949Phase 1
- AFP464 in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By SurgeryCompletedNCT00348699Phase 1
- Case-Control Study of Renal Cell Cancer Among Caucasions and African Americans in the United StatesCompletedNCT00340457
- Safety and Biological Activity of TroVax® Vaccine Given With IL-2 in Renal Cell CarcinomaCompletedNCT00325507Phase 2
- Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney CancerTerminatedNCT00323791Phase 2
- [18]F-FAZA PET Imaging Study in Patients With Cancer of the Head & Neck, Lung, Renal Cell, Brain, Lymphoma and Neuroendocrine TumoursTerminatedNCT00323076Phase 1/2
- Matched Unrelated Donor Transplant for Metastatic Renal Cell CarcinomaTerminatedNCT00318110Phase 2
- Positron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical TrialCompletedNCT00316901Phase 2
- S0351, CNTO 328 in Treating Patients With Unresectable or Metastatic Kidney CancerWithdrawnNCT00311545Phase 2
- Combined Treatment With Capecitabine and Immunotherapy Versus Immunotherapy Alone in Advanced Renal Cell CarcinomaTerminatedNCT00311467Phase 3
- Mechanism of Action of High-Dose IL-2 (Aldesleukin) in Metastatic Melanoma and Kidney CancerCompletedNCT00304460Phase 1
- Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney CancerStatus unknownNCT00301990Phase 2
- Sorafenib in Treating Patients With Kidney Cancer That Has Spread to the BrainCompletedNCT00301847Phase 2
- Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic AnemiaStatus unknownNCT00295997Not applicable
- Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By SurgeryStatus unknownNCT00293501Phase 1/2
- Cytokines in Patients With Metastatic Renal Cell Carcinoma of Intermediate PrognosisCompletedNCT00291369Phase 3
- Comparison of Immune Response Following Surgical Management of Renal TumorsTerminatedNCT00289146
- Interferon Alfa (IFN-Alpha-1b) in Renal Cancer With Metastatic Kidney CancerCompletedNCT00278174Phase 2
- Study of XL999 in Patients With Metastatic Renal Cell CarcinomaTerminatedNCT00277316Phase 2
- Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, & Thalidomide for Metastatic, Advanced or Recurrent Renal Cell CarcinomaCompletedNCT00277017Phase 1/2
- Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney CancerCompletedNCT00276835Early Phase 1
- Study Testing the Biologic Activity and Safety of an Immunotherapeutic in Patients With Newly Diagnosed Stage IV Kidney CancerCompletedNCT00272649Phase 1/2
- A Study of CNTO 328 in Subjects With Metastatic Renal Cell CarcinomaCompletedNCT00265135Phase 1/2
- Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney CancerCompletedNCT00262886Phase 2
- Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV MelanomaCompletedNCT00258687Phase 1
- Pazopanib (GW786034) In Subjects With Relapsed Or Refractory Multiple MyelomaCompletedNCT00256880Phase 2
- Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Metastatic Kidney Cancer That Cannot Be Removed By SurgeryTerminatedNCT00243009Phase 2
- A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell CarcinomaCompletedNCT00226980Phase 2
- Immunochemotherapy for Metastatic Renal Cell CarcinomaStatus unknownNCT00226798Phase 2
- Azacitidine and Recombinant Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By SurgeryCompletedNCT00217542Phase 1
- Relationship of Ochratoxin A to Upper Urologic CancersCompletedNCT00216801
- Trial of G250 Peptide and IL-2 Following Surgical Resection of Locally Advanced/Metastatic Renal Cell CarcinomaTerminatedNCT00203866Phase 2
- Dendritic Cell Based Therapy of Renal Cell CarcinomaCompletedNCT00197860Phase 1/2
- OSI-774 and Bevacizumab in the Treatment of Patients With Metastatic Renal Cell CarcinomaCompletedNCT00193154Phase 2
- Bortezomib and Bevacizumab ("BB-mib-mab") in Patients With Advanced or Recurrent Renal Cell Cancer (RCC)Status unknownNCT00184015Phase 1/2
- Ixabepilone in Treating Patients With Metastatic, Recurrent, or Unresectable Kidney CancerCompletedNCT00182702Phase 2
- Randomized Phase 2 Trial of Pre-chemotherapy Leukine vs. Leukine-Dexamethasone in Combination With Gemzar & 5-FU in Patients With Metastatic Renal Cell CarcinomaWithdrawnNCT00176280Phase 2
- Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone MetastasisCompletedNCT00172003Phase 4
- Oral Topotecan As A Radiosensitizing Agent In Rectal CancerTerminatedNCT00158886Phase 1
- Study Of Safety And Tolerability Of GW786034 Given With Lapatinib In Cancer PatientsCompletedNCT00158782Phase 1
- Efficacy of Activated Lymphocytes in Renal Cell Carcinoma.TerminatedNCT00151645Phase 2
- Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) CancerCompletedNCT00134186Phase 2
- ATN-161 in Advanced Renal Cell CancerTerminatedNCT00131651Phase 2
- Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell CarcinomaApproved for marketingNCT00130897
- Clinical Trial Studying a Personalized Cancer Vaccine in Patients With Non-metastatic Kidney CancerTerminatedNCT00126178Phase 3
- Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT00112476Phase 1
- Treatment Protocol for the Use of Sorafenib in Patients With Advanced Renal Cell CarcinomaCompletedNCT00111020Phase 3
- Research Study for Patients With Metastatic Renal Cell CarcinomaTerminatedNCT00110344Phase 2
- A Research Study for Patients With Metastatic Renal Cell CarcinomaCompletedNCT00106613Phase 2
- Continuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Completed Prior Study With FK228CompletedNCT00106301Phase 2
- Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung CancerCompletedNCT00101348Phase 1/2
- Sorafenib and Interferon Alfa in Treating Patients With Metastatic or Unresectable Kidney CancerCompletedNCT00101114Phase 2
- Sequential ATRA Then IL-2 for Modulation of Dendritic Cells and Treatment of Metastatic Renal Cell CancerCompletedNCT00100906Phase 2
- Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC)TerminatedNCT00100685Phase 2
- Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney CancerTerminatedNCT00098618Phase 2
- Vaccine Therapy in Treating Patients With Kidney CancerCompletedNCT00096629Phase 1
- Lenalidomide in Treating Patients With Advanced or Unresectable Kidney CancerCompletedNCT00096525Phase 2
- Safety/Efficacy Study of Oral Recombinant Human Lactoferrin in Renal Cell CarcinomaCompletedNCT00095186Phase 2
- Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney CancerStatus unknownNCT00093522Phase 2
- 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Kidney CancerCompletedNCT00093405Phase 2
- Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous TreatmentCompletedNCT00091182Phase 2
- Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00089362Phase 1
- RNA-Loaded Dendritic Cell Cancer VaccineCompletedNCT00087984Phase 1/2
- A Study of TroVax Vaccine Given in Conjunction With IL-2 for Treatment of Stage IV Renal Cell CancerCompletedNCT00083941Phase 2
- Fluorouracil and Low-Dose Suramin as Chemosensitization in Treating Patients With Metastatic Renal Cell (Kidney) CancerCompletedNCT00083109Phase 1/2
- Denileukin Diftitox in Treating Patients With Metastatic Melanoma or Metastatic Kidney CancerCompletedNCT00082914Phase 2
- Trial to Compare the Routes of Administration of an Investigational, Personalized, Therapeutic Cancer Vaccine Oncophage (HSPPC-96) in Patients With Metastatic Renal Cell CarcinomaTerminatedNCT00082459Phase 2
- A Study Evaluating Tarceva in Combination With Avastin Versus Avastin Alone in Treating Metastatic Renal Cell CarcinomaCompletedNCT00081614Phase 2
- High-Dose Intravenous Interleukin-2 in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer) That Has Not Responded to Previous Low-Dose Intravenous or Subcutaneous Interleukin-2Status unknownNCT00080977Phase 2
- Study of Nexavar (Sorafenib, BAY 43-9006) in Patients With Advanced Refractory CancerCompletedNCT00079612Phase 2
- Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell TransplantCompletedNCT00078858Phase 1/2
- Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell CancerCompletedNCT00077129Phase 2
- 3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell CarcinomaCompletedNCT00075660Phase 2
- Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell TransplantationCompletedNCT00073879Not applicable
- Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell CarcinomaCompletedNCT00073125Phase 2
- A Study of ABT-751 in Patients With Renal Cell CancerCompletedNCT00073112Phase 2
- Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)CompletedNCT00072046Phase 3
- Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV)SuspendedNCT00065572Phase 2
- Efficacy and Safety Study of rhuMAb VEGF to Treat Metastatic Renal Cell CarcinomaWithdrawnNCT00061178Phase 3
- Erlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell CancerCompletedNCT00060307Phase 2
- Oblimersen and Interferon Alfa in Treating Patients With Metastatic Renal Cell CancerCompletedNCT00059813Phase 2
- A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell CarcinomaCompletedNCT00059735Phase 2